Status:
COMPLETED
Pharmacokinetics and Dynamics of Dexmedetomidine as Adjuvant in TAP Block
Lead Sponsor:
Assiut University
Conditions:
Postoperative Pain
Eligibility:
All Genders
18-60 years
Phase:
PHASE2
PHASE3
Brief Summary
TAP-block has been shown to be a safe and effective postoperative analgesia method in a variety of general. Dexmedetomidine is a selective α2 agonist with 8 times more affinity for α2 adrenergic recep...
Eligibility Criteria
Inclusion
- 24 ASA I-II
- patients (age 18-60 years
- weight 50-89 kg
Exclusion
- a known allergy to the study drugs
- significant cardiac
- respiratory, renal or hepatic diseases
- bleeding diathesis
Key Trial Info
Start Date :
November 11 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2019
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT03328299
Start Date
November 11 2017
End Date
September 1 2019
Last Update
October 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
South Egypt Cancer instIitute
Asyut, Egypt, 171516